Surgery Financing vs Traveling Abroad: Which Saves More?

Medical credit cards solve the cash-flow problem. They don't solve the total-cost problem. Here's the actual math.

Bottom line up front: Medical financing solves a cash-flow problem, not a cost problem — and deferred-interest medical credit cards can add substantial cost if the balance isn't paid off within the promotional window.

How medical financing typically works

Medical credit products (like CareCredit and similar programs) often offer a promotional 0% period, followed by deferred interest applied retroactively to the full original balance if it isn't paid off in time — typically in the 15–30% APR range once that window closes. This structure is common industry-wide; always read your specific card's terms, since they vary by issuer and promotion.

A simplified comparison

ScenarioProcedure costFinancing cost if not paid in promo windowEffective total
US, financed, paid off in time$40,000$0 (0% promo honored)$40,000
US, financed, missed promo window$40,000Deferred interest on full balanceCan exceed $50,000+
Colombia, self-pay, no financing needed$12,000–$25,000n/a$12,000–$25,000 + travel

Even accounting for flights and lodging, the self-pay-abroad total in this simplified example remains well below the domestic financed total — and carries none of the deferred-interest risk.

When financing domestically still makes sense

If continuity of care outweighs cost for your specific situation (see our decision framework on medicaltourismabroad.com's Briefing), or if you can reliably pay off a 0% promotional balance in full within the window, domestic financing can be the lower-risk choice despite the higher sticker price.

This comparison holds across categories — see the specific pricing on colombiacosmeticsurgery.com or colombiadentist.co to run your own numbers.

The Takeaway

Run the real math on your specific card's terms before assuming financing domestically is cheaper — a missed promotional deadline can flip the comparison entirely.